Real-world cure rates for hepatitis C virus treatments that include simeprevir and/or sofosbuvir are comparable to clinical trial results

AIM: To assess the real-world effectiveness and cost of simeprevir (SMV), and/or sofosbuvir (SOF)-based therapy for chronic hepatitis C virus (HCV) infection. METHODS: The real-world performance of patients treated with SMV/SOF ± ribavirin (RBV), SOF/RBV, and SOF/RBV with pegylated-interferon (PEG)...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:World J Virol
Main Authors: Bichoupan, Kian, Tandon, Neeta, Crismale, James F, Hartman, Joshua, Del Bello, David, Patel, Neal, Chekuri, Sweta, Harty, Alyson, Ng, Michel, Sigel, Keith M, Bansal, Meena B, Grewal, Priya, Chang, Charissa Y, Leong, Jennifer, Im, Gene Y, Liu, Lawrence U, Odin, Joseph A, Bach, Nancy, Friedman, Scott L, Schiano, Thomas D, Perumalswami, Ponni V, Dieterich, Douglas T, Branch, Andrea D
Formato: Artigo
Idioma:Inglês
Publicado: Baishideng Publishing Group Inc 2017
Assuntos:
Observational Study
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5680347/
https://ncbi.nlm.nih.gov/pubmed/29147645
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5501/wjv.v6.i4.59
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares